stockioi: Stockioi watch list for: Thursday, April 26, 2007 (OTCBB: LDTI), (OTCBB: BLFS), (OTC: PDGT), (OTCBB: BLGA), (OTC: CYRX), (OTCBB: TSSW)
4/26/2007 9:03:22 AM
Apr 26, 2007 (M2 PRESSWIRE via COMTEX) -- Stockioi Alerts for Thursday include: Leisure Direct Inc ( LDTI ), BioLife Solutions Inc ( BLFS ), Paradigm Tactical Products ( PDGT ), BlastGard International Inc ( BLGA ), CryoPort Inc ( CYRX ), Touchstone Software Corp ( TSSW )
LEISURE DIRECT INC ( LDTI ) "Up 68.27% on Wednesday"
stockioi.com
It is the mission of LDTI to become the premier, highest quality and most nationally recognized manufacturer and direct marketer of pool, spa/hot tub, and patio products in the United States. LDTI will implement its strategy by acquiring existing manufacturers of backyard entertainment products and building a direct marketing distribution network.
LDTI News:
April 24 - Leisure Direct Announces Opening of Dealer Location in Cincinnati
Leisure Direct, Inc. ( LDTI ) announced Tuesday that it will open a retail store in a prime location in Cincinnati, Ohio. The location will sell spas manufactured by Royal Spa Manufacturing along with a variety of other leisure products. John Ayling, Chairman of Leisure Direct, stated, "We will be located in a prime location to capture market share and serve our customers in the Cincinnati area. Revenue from the operation will begin to be booked this quarter. This is only the first of many company-owned dealer and service locations as Leisure Direct begins to execute its business plan. Our initial thrust will be locations in the Midwest region of the country."
Leisure Direct has hired an industry veteran from the Cincinnati area to lead sales and installation services from the location. The location will operate under a company brand name that signifies Leisure Direct's intent to sell and install products that are both complementary to spas/hot tubs and part of the "backyard" leisure industry.
Robert Dapper, President of Leisure Direct and founder of Royal Spas, stated, "We will quickly establish the location as a premier dealer and will leverage Royal Spas' proven sales and marketing approach to drive first year sales at the Cincinnati location to between $1 million and $1.5 million, with EBITDA in the $120,000 to $150,000 range. Within two or three years, we fully expect to book more than $2 million of revenue annually."
Leisure Direct's business plan includes acquiring or opening 50 to 60 locations over the next three to five years, with 10 to 15 of them being consummated in 2007. Leisure Direct will begin to announce dealer acquisitions over the next few days and weeks. Once its initial dealer network is established, the company intends to acquire manufacturers of spas/hot tubs.
BIOLIFE SOLUTIONS INC ( BLFS ) "Up 61.90% on Wednesday"
stockioi.com
Incorporated in March 1998, BioLife Solutions, Inc. (OTCBB: BLFS.OB) develops, manufactures and markets low temperature technologies for use in preserving and prolonging the viability of cellular and genetic material for use in cell therapy and tissue engineering. The Companys patented HypoThermosol platform technology is used to provide customized preservation solutions which significantly prolong cell, tissue and organ viability, which could, in turn improve clinical outcomes for new and existing cell and tissue therapy applications, as well as for organ transplantation.
The Companys line of preservation solutions is composed of complex synthetic, aqueous solutions containing, in part, minerals and other elements found in human blood, which are necessary to maintain fluids and chemical balances throughout the body at near freezing temperatures. The solutions preserve cells and tissue in low temperature environments for extended periods after removal of the cells through minimally invasive biopsy or surgical extraction, as well as in shipping the propagated material for the application of cell or gene therapy or tissue engineering.
BioLife has entered into research agreements with several emerging biotechnology companies engaged in the research and commercialization of cell and gene therapy technology and has received several government research grants to conduct basic research, which could lead to further commercialization of technology to preserve human cells, tissues and organs. Since 2000, BioLife has been awarded six National Institute of Health (NIH) grants and one National Science Foundation grant, valued at $1.2 million.
BLFS News:
April 25 - BioLife Solutions Grants Product License to Centocor Research & Development, Inc.
BioLife Solutions Inc. ( BLFS ) a leading manufacturer of proprietary preservation media products for cells and tissues, announced Wednesday that it has granted a product license to Centocor Research & Development, Inc. The agreement provides Centocor with certain rights to long term access to BioLife's CryoStor DLite reduced DMSO cryopreservation media. CryoStor DLite is used in the production of Centocor's emerging cell therapy products targeting several clinical applications. Financial terms of the licensing agreement were not disclosed.
'We are extremely pleased to work with Centocor by providing enabling technology for the development and commercialization of new cell therapy products,' said Mike Rice, chief executive officer, BioLife Solutions. 'This agreement reinforces the strength of our intellectual property portfolio and may demonstrate the unique advantages of improved post-preservation cell viability and function that our products provide to academic researchers and cell therapy companies.'
According to an August 2006 research report published by Jain PharmaBiotech, the total value of cell based markets was $26.6 billion in 2005 and is expected to grow to $96.3 billion in 2015. More than 300 companies are engaged in the development and commercialization of new cellular based therapies.
PARADIGM TACTICAL PRODUCTS ( PDGT ) "Up 45% on Wednesday"
stockioi.com
Paradigm Tactical Products, based in Georgetown, Massachusetts, is a leading provider of non-lethal defense and homeland security solutions to corrections, law enforcement and security industry. The Company acquired the exclusive transferable license to manufacture, market and sell the FriskerPro, the only patented, hand worn metal detection device. As the heightened attentiveness to terrorist and other security threats continue to increase, Paradigm Tactical is ramping up its production and marketing efforts to meet the higher demand for security and inspection systems. The Company has sold over 2,000 FriskerPro hand worn metal detectors and the FriskerPro is currently being used or tested by 13 Federal departments and agencies, six state law enforcement and correctional agencies and eight local agencies. For more information, visit: paradigmtactical.com.
PDGT News:
April 25 - Cleveland Police, United Kingdom Expanding Use of FriskerPRO(R)
Paradigm Tactical Products ( PDGT ), a leading provider of non-lethal defense and homeland security solutions to corrections, law enforcement and the security industry, announced Wednesday the Cleveland Police, United Kingdom, are expanding their use of the FriskerPRO hand worn metal detector.
The Cleveland Police, located in the United Kingdom, polices an area 230 square miles, divided into four territorial police districts: Hartlepool, Redcar & Cleveland, Middlesbrough and Stockton. The Cleveland Police oversees a number of potentially hazardous sites, which include but are not limited to one of the largest and busiest ports in the United Kingdom in terms of tonnage as well as two prisons including Holme House category B prison.
Chief Superintendent Graham Cummings is quoted as stating, "Cleveland Police have been using the Eazysearch / FriskerPro metal detector for the last seven months within the custody suite environment. The Officers and staff have found the equipment easy and comfortable to use and we feel as a tool it is of great help in securing evidence, ensuring the safety of staff and detained persons. I intend to expand its use within the Custody Environment and present it to the Force to consider using in the patrol environment."
Camilla Cutler, Business Manager for Paradigm Tactical Products said, "The FriskerPRO is gaining increasing recognition, nationally and internationally. Establishing a long-term business relationship with Eazytext, to distribute the FriskerPRO throughout the United Kingdom, has enabled customers such as Chief Superintendent Graham Cummings to incorporate this tool in their daily searches. Paradigm anticipates increasing awareness of the FriskerPRO throughout the United Kingdom."
BLASTGARD INTERNATIONAL INC ( BLGA ) "Up 42.86% on Wednesday"
stockioi.com
BlastGard International, Inc. creates, designs, develops, manufactures and markets proprietary blast mitigation materials. The Company's patent-pending BlastWrap(R) technology effectively mitigates blast effects and suppresses post-blast fires. This unique technology can be used to create new, finished products or be used to retrofit to existing products. While the need for this technology has always been present, the security and safety concerns resulting from the September 11, 2001, acts and the subsequent development of Homeland Security make the timing of the Company's emergence even more important. The Company's core market focus is on blast effects mitigation for the commercial sector, military, law enforcement and government agencies. BlastWrap(R) is based upon well-defined principles and suppresses blast pressures by 50% or more. BlastWrap(R) products are made from two flexible films arranged one over the other and joined by a plurality of seams filled with attenuating filler material (volcanic glass bead or other suitable two-phase materials), configurable (designed for each application) with an extinguishing coating that offers a revolutionary blast protection system against Blast & Fire/burn threats. BlastWrap(R) is a blast mitigation assembly that can be wrapped around or conform to any shape. BlastWrap(R) is a concept (not a chemical compound) from which blast protection products are built to save lives and reduce damage to valuable assets from explosions. Additional information on BlastGard can be found at blastgardintl.com.
BLGA News:
April 25 - BlastGard International Raises Approximately $3.0 Million in Equity Financing
BlastGard International, Inc. ( BLGA ) has a plan of financing and has raised approximately $3,000,000 from the sale of its Common Stock at $.30 per share and 18 month Warrants exercisable at $.45 per share. The financing is ongoing and no assurances can be given that additional financing will be raised. The proceeds raised will provide BlastGard with working capital for its operations. Furthermore, Andrew McKinnon, our new Chief Operating Officer, has entered into an Agreement to purchase $1,200,000 of our outstanding indebtedness and, upon completion of such purchase, he has indicated to the Board that he and any other purchasers of such debt will convert same into 4,000,000 shares of Common Stock.
CYROPORT INC ( CYRX ) "Up 37.50% on Wednesday"
stockioi.com
CryoPort ( www.cryoport.com) develops leading edge, proprietary, technology driven shipping and storage products for use in the rapidly growing global biotechnology and biopharmaceutical sectors. The products are essential components of the infrastructure required for the testing, research and end user delivery components that make up the foundation of the biopharmaceutical and biotechnology industries.
CYRX News:
April 23 - CryoPort Reports Successful Pilot Shipments for Multiple Pharmaceutical Companies
CryoPort, Inc. ( CYRX ) announced recently that it has successfully completed pilot shipments of the CryoPort Express One Way Shipper System involving medicines and biomaterials with selected pharmaceutical manufacturers.
The shipments included such destinations as Thailand and India. In addition, research biomaterials are currently shipping to South Africa. CryoPort's CEO, Mr. Peter Berry, commented, "These successful pilot shipments are particularly significant as they confirm the application of our one-way technology in shipping to locations that have historically provided significant challenges for cold chain shipments within global clinical trials. Due to the sensitivity of R&D activities within the pharmaceutical sectors, we are not able to discuss the names of our pilot partners at this time, although I am hopeful that as their programs mature we will be able to share this information with our investors."
Mr. Berry concluded, "As our pilot program partners continue to increase their usage of the CryoPort Express platform, we are responding by taking the initial steps to establish a foundation for ramping up our manufacturing to a larger scale in an effort to meet the anticipated demand for our products."
TOUCHSTONE SOFTWARE CORP ( TSSW ) "Up 36.59% on Wednesday"
stockioi.com
TouchStone Software Corporation ( TSSW ) is a leading developer of innovative software designed to help people use complex technologies. The company's products, which include BIOS Agent, BIOS Wizard and Driver Agent, are distributed worldwide via the Internet. TouchStone's corporate headquarters are located at 1538 Turnpike Street, North Andover, MA 01845. Additional information on the Driver Agent service is available at www.driveragent.com and a one year subscription is $29.95. Additional information about TouchStone Software is available at www.touchstonesoftware.com.
TSSW News:
April 25 - TouchStone Software Corporation Reports Q1 Revenue of $1,102,026 and Earnings of 3 Cents per Share - Best Earnings Results in over 10 Years
TouchStone Software Corporation ( TSSW ) recently announced that for the quarter ending March 31, 2007, net revenue was $1,102,026. On a GAAP basis, TouchStone Software's first quarter net earnings were $310,225, or $0.03 per share diluted, which are the best reported quarterly earnings since 1995. As a percentage of sales, gross profit margin for the first quarter improved to 96% as compared to 85% for the same period in 2006. Net operating margin for the first quarter was 28% as compared to 26% for the same period in 2006.
Stockioi finds undervalued stocks exhibiting the potential for explosive breakouts using a winning combination of technical disciplines and cutting edge perspective. Sign up today for our free newsletter and start finding out why our picks are gaining so much small cap investor attention Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on stockioi.com Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice. Reproduction without written permission is prohibited.
CONTACT: Stockioi - ioi, inc. Tel: +1 800 940 6559
|
